Systemic Sclerosis Association with Malignancy

Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557–567

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10

PubMed  Article  Google Scholar 

Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755

CAS  PubMed  Article  Google Scholar 

Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809–1815

PubMed  Article  Google Scholar 

Noureldine HA, Nour-Eldine W, Hodroj MH, Noureldine MHA, Taher A, Uthman I (2020) Hematological malignancies in connective tissue diseases. Lupus 29(3):225–235

CAS  PubMed  Article  Google Scholar 

Volkmann ER, Fischer A (2021) Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease. J Scleroderma Relat Disord 6(1):11–20

PubMed  Article  Google Scholar 

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A et al (2017) Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897–1905

Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219

PubMed  Article  Google Scholar 

Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O (1995) Incidence of cancer among patients with systemic sclerosis. Cancer 76:910–914

CAS  PubMed  Article  Google Scholar 

Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460–464

CAS  PubMed  Article  Google Scholar 

Roumm AD, Medsger TA Jr (1985) Cancer and systemic sclerosis. An epidemiologic study Arthritis Rheum 28:1336–1340

CAS  PubMed  Article  Google Scholar 

Olesen AB, Svaerke C, Farkas DK, Sørensen HT (2010) Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163(4):800–806

CAS  PubMed  Article  Google Scholar 

Partouche L, Goulabchand R, Maria ATJ, Rivière S, Jorgensen C, Rigau V et al (2020) Biphasic temporal relationship between cancers and systemic sclerosis: a clinical series from Montpellier University Hospital and Review of the Literature. J Clin Med 9(3):853

PubMed Central  Article  Google Scholar 

Schottenfeld D, Beebe-Dimmer J (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56:69–83

PubMed  Article  Google Scholar 

Roberts-Thomson PJ, Male DA, Walker JG, Cox SR, Shen X, Smith MD et al (2004) Genomic instability in scleroderma. Asian Pac J Allergy Immunol 22:153–158

CAS  PubMed  Google Scholar 

Leone G, Pagano L, Ben-Yehuda D, Voso MT (2007) Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 92:1389–1398

CAS  PubMed  Article  Google Scholar 

Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G (2008) Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin Rheumatol 27(9):1163–1166

PubMed  Article  Google Scholar 

Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52:531–533

CAS  PubMed  PubMed Central  Article  Google Scholar 

Morrisroe KB, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS et al (2020) Incidence, Risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res (Hoboken) 72(11):1625–1635

CAS  Article  Google Scholar 

Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S (2003) Tumors as elusive targets of T-cell-based active immunotherapy. Mechanisms of Immune Evasion by Tumors. Trends Immunol 24:334–41

Duncan SC, Winkelmann RK (1979) Cancer and scleroderma. Arch Dermatol 115:950–955

CAS  PubMed  Article  Google Scholar 

Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population-based cohort study. Ann Rheum Dis 62:728–731

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chatterjee S, Dombi GW, Severson RK, Mayes MD (2005) Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52:2415–2424

PubMed  Article  Google Scholar 

Derk CT, Rasheed M, Artlett CM, Jiminez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33:1113–1116

PubMed  Google Scholar 

Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101(1):59–62

PubMed  Article  Google Scholar 

Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C et al (2013) Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 52(1):143–154

Article  Google Scholar 

Pontifex EK, Hill CL, Roberts-Thomson P (2007) Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Ann Rheum Dis 66(4):551–553

PubMed  Article  Google Scholar 

Kaşifoğlu T, Yaşar Bilge Ş, Yıldız F, Özen G, Pehlivan Y, Yılmaz N et al (2016) Risk factors for malignancy in systemic sclerosis patients. Clin Rheumatol 35(6):1529–1533

PubMed  Article  Google Scholar 

Siau K, Laversuch CJ, Creamer P, O’Rourke KP (2011) Malignancy in scleroderma patients from south west England: a population-based cohort study. Rheumatol Int 31:641–645

PubMed  Article  Google Scholar 

Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65(7):1913–1921

PubMed  Article  Google Scholar 

Zhong H, Zhou J, Zhang S, Xu Y, Hou Y, Li M et al (2021) Risk and prognosis factors for systemic sclerosis with lung cancer: a single-centre case-control study in China. Int J Clin Pract 75(4):e13819

Chen M, Liu X, Xu Y, Zhou Q, Shi Y, Zhang D et al (2020) Clinicopathological characteristics of lung cancer in patients with systemic sclerosis. Clin Respir J 14(12):1131–1136

CAS  PubMed  Article  Google Scholar 

Colaci M, Giuggioli D, Sebastiani M, Manfredi A, Vacchi C, Spagnolo P et al (2013) Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. Autoimmun Rev 12:374–379

PubMed  Article  Google Scholar 

Catano J, Guedon A, Riviere S, Carrat F, Mahevas T, Fain O et al (2019) Cancers in systemic Sclerosis: risk factors, impact on survival and literature review. Rev Med Interne 40(10):637–644

CAS  PubMed  Article  Google Scholar 

Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY, Chang HC et al (2012) Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 41(1):44–49

PubMed  Article  Google Scholar 

Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM (1985) Incidence of lung cancer in systemic sclerosis. J Rheumatol 12:1136–1139

CAS  PubMed  Google Scholar 

Szekanecz E, Szamosi S, Horvàth A, Németh A, Juhàsz B, Szàntò J et al (2012) Malignancies associated with systemic sclerosis. Autoimmun Rev 11(12):852–855

CAS  PubMed  Article  Google Scholar 

Peng H, Wu X, Wen Y, Li C, Lin J, Li J et al (2020) Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis. Autoimmun Rev 19(10):102633

Colaci M, Giuggioli D, Vacchi C, Lumetti F, Iachetta F, Marcheselli L et al (2014) Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based cancer registry and review of the literature. Autoimmun Rev 13:132–137

PubMed  Article  Google Scholar 

Maria ATJ, Partouche L, Goulabchand R, Rivière S, Rozier P, Bourgier C et al (2019) Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol 10(9):3112

Article  CAS  Google Scholar 

Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B et al (2004) Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 23(6):516–522

PubMed  Article  Google Scholar 

Talbott JH, Barrocas M (1979) Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 58:182–207

CAS  Article  Google Scholar 

Forbes AM, Woodrow JC, Verbov JL, Graham RM (1989) Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 28:65–69

CAS  PubMed  Article  Google Scholar 

Bielefeld P, Meyer P, Caillot D, Dalac S, Camus P, Tavernier C et al (1996) Systemic scleroderma and cancers: 21 cases and review of the literature (in French). Rev Med Interne 17:810–813

CAS  PubMed  Article  Google Scholar 

留言 (0)

沒有登入
gif